ELAINA RICCI: Open Payments
NPI 1194785089 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 41 payments from 16 companies in 2025. Trend: 2023 $871 · 2024 $1,143 · 2025 $956
Food & beverage: $871Education: $85
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 6 | $157 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $118 |
| UCB, Inc. | 4 | $89 |
| GENZYME CORPORATION | 4 | $82 |
| PFIZER INC. | 4 | $71 |
| Amgen Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Galderma Laboratories, L.P. | 2 | $39 |
Products named: ADBRY, Bimzelx, DUPIXENT, CIBINQO, OTEZLA, LIBTAYO, NEMLUVIO, SOFDRA.
Industry payments across TX — which companies pay providers there.
